Login / Signup

The Next Generation Fecal Microbiota Transplantation: To Transplant Bacteria or Virome.

You YuWeihong WangFaming Zhang
Published in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Fecal microbiota transplantation (FMT) has emerged as a promising therapeutic approach for dysbiosis-related diseases. However, the clinical practice of crude fecal transplants presents limitations in terms of acceptability and reproductivity. Consequently, two alternative solutions to FMT are developed: transplanting bacteria communities or virome. Advanced methods for transplanting bacteria mainly include washed microbiota transplantation and bacteria spores treatment. Transplanting the virome is also explored, with the development of fecal virome transplantation, which involves filtering the virome from feces. These approaches provide more palatable options for patients and healthcare providers while minimizing research heterogeneity. In general, the evolution of the next generation of FMT in global trends is fecal microbiota components transplantation which mainly focuses on transplanting bacteria or virome.
Keyphrases
  • healthcare
  • cell therapy
  • clinical practice
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • ejection fraction
  • prognostic factors
  • single cell
  • social media
  • health insurance
  • smoking cessation